American Bio Medica Corp. (ABMC)
|Net Income (ttm)||-796,000|
|Trading Day||May 14|
|Day's Range||0.0610 - 0.0700|
|52-Week Range||0.0600 - 1.2400|
There are no news available yet.
American Bio Medica Corporation develops, manufactures, and sells lateral flow immunoassay tests primarily for the immediate detection of drugs in urine and oral fluids. Its drugs detection products in urine include Rapid Drug Screen, a rapid drug test, which detects the presence or absence of 2 to 10 drugs; RDS InCup, a drug-testing cup that detects the presence or absence of 1 to 12 drugs; Rapid TOX, a drug test in a cassette platform, which detects the presence or absence of 1 to 10 drugs; and Rapid TOX Cup II, a drug testing cup that detect... [Read more...]
Diagnostics & Research
|IPO Date |
Dec 24, 1997
|Stock Exchange |
|Ticker Symbol |
In 2020, ABMC's revenue was $4.15 million, an increase of 13.46% compared to the previous year's $3.66 million. Losses were -$796,000, 16.9% more than in 2019.